On August 10, 2026, Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) disclosed a collaboration agreement with Tianjin Yuanshan Medical Technology Co., Ltd., known as Alpmed, a Chinese company recognized for its advancements in irreversible electroporation (IRE) technology. This strategic partnership aims to concentrate on the worldwide advancement and market launch of cutting-edge IRE technologies.